サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641762

ハイパーサーミア装置の世界市場：製品別、用途別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年

Hyperthermia Devices Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 290 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ハイパーサーミア装置の世界市場：製品別、用途別、エンドユーザー別 - 機会分析と産業予測、2024年～2033年
出版日: 2024年12月01日
発行: Allied Market Research
ページ情報: 英文 290 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ハイパーサーミア装置市場は、2023年に1億6,820万米ドルとなり、2024年から2033年にかけてCAGR5.6％で成長し、2033年までには2億9,010万米ドルに達すると予測されています。

Hyperthermia Devices Market-IMG1

ハイパーサーミア装置は、治療目的で体組織の温度を上げるために使用される医療機器であり、多くの場合、がんの補助治療として使用されます。身体の特定部位に制御された熱を加えることで、血流を改善し、治療に対するがん細胞の感受性を高めることにより、化学療法や放射線療法などの治療効果を高めます。

ハイパーサーミア装置の世界市場の成長は、世界のがん患者の増加により、化学療法や放射線療法といった従来のがん治療の効果を向上させるハイパーサーミア装置を含む革新的な治療法に対する需要が高まっていることが背景にあります。世界保健機関（WHO）が発表した2022年の調査によると、がんは世界の主要死因であり、2020年には約1,000万人が死亡しています。そのため、より侵襲の少ないがん治療を求める患者が増加する中、ハイパーサーミア装置は、従来のアプローチと比較して副作用を最小限に抑えながら局所組織をターゲットにできることから人気を博しています。さらに、治療成績の向上と副作用の軽減における役割を含むハイパーサーミア療法の利点に対する認識の高まりが、臨床現場での受け入れ拡大につながりました。さらに、治療成績の向上や副作用の軽減における役割を含め、ハイパーサーミア療法の利点に関する意識の高まりが、臨床現場での受け入れ拡大につながり、市場の成長を促進しています。さらに、高齢者人口の急増が世界市場の主要な推進力となっています。これは、加齢が異常細胞やがん細胞に対する監視機能の低下など、免疫系の効率低下に関連しているという事実に起因しています。このため、ハイパーサーミア装置を含む高度な治療オプションに対する大きな需要が生まれています。世界保健機関（WHO）が発表した2024年の調査では、高齢者の数が2020年の10億人から、2030年までには14億人に増加することが明らかになりました。さらに、80歳以上の高齢者の数は、2050年までに4億2,600万人に達すると推定されています。世界の腫瘍専門クリニックや病院の増加は、患者の転帰を改善するために、ハイパーサーミア療法などの高度ながん治療法の採用をさらに促進しています。その利点にもかかわらず、ハイパーサーミア療法は、その有効性とがん治療プロトコールへの統合に関するヘルスケア提供者の認識とトレーニングが限られているため、まだ十分に活用されていません。特に中低所得地域では、機器や関連処置を含むハイパーサーミア治療の費用は、多くの患者やヘルスケアシステムにとって法外であり、市場の成長をさらに抑制しています。それとは逆に、改良された温熱送達システム、リアルタイムの温度モニタリング、非侵襲的装置などの技術革新は、ハイパーサーミア治療の安全性、正確性、有効性を高めています。このような開発は、予測期間中の世界市場拡大に有益な機会を提供すると期待されます。

ハイパーサーミア装置の世界市場分析は、製品、用途、エンドユーザー、地域に区分されます。製品ベースでは、市場はマイクロ波ハイパーサーミア装置と超音波ハイパーサーミア装置に分類されます。用途別では、乳がん、前立腺がん、子宮頸がん、その他に分別されます。エンドユーザー別では、病院、がん治療センター、その他に細分化されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで分析されています。

主要な調査結果

製品別では、超音波ハイパーサーミア装置分野が2024年から2033年にかけて市場を独占すると予測されます。

用途別では、前立腺がん分野が予測期間を通じて最も高い成長を示すと予測されています。

エンドユーザー別では、病院セグメントが予測期間中に顕著なペースで成長すると予測されています。

地域別では、北米が2023年に収益ベースで最大の市場シェアを占め、予測期間中も市場を独占する可能性が高いです。

世界のハイパーサーミア装置市場で事業を展開している主要企業には、Pyrexar Medical、Oncotherm、Celsius42、Andromedic、Pearson、Nanjing Greathope、Shanghai Huayuan、MagForce AG、Nanopores、Sensiusなどがあります。これらの主要企業は、競争市場での足場を固めるために、事業拡大、新製品投入、提携など様々な主要開発戦略を採用しています。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 国、地域、世界レベルでの患者/疫学データ
  • 規制ガイドライン
  • クライアントの関心に応じた追加企業プロファイル
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • SWOT分析

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な投資機会
    • 主要な成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 ハイパーサーミア装置市場：製品別

  • 市場概要
  • マイクロ波ハイパーサーミア装置
  • 超音波ハイパーサーミア装置

第5章 ハイパーサーミア装置市場：用途別

  • 市場概要
  • 乳がん
  • 前立腺がん
  • 子宮頸がん
  • その他

第6章 ハイパーサーミア装置市場：エンドユーザー別

  • 市場概要
  • 病院
  • がん治療センター
  • その他

第7章 ハイパーサーミア装置市場：地域別

  • 市場概要
  • 北米
    • 主要な市場動向と機会
    • 米国のハイパーサーミア装置市場
    • カナダのハイパーサーミア装置市場
    • メキシコのハイパーサーミア装置市場
  • 欧州
    • 主要市場動向と機会
    • フランスのハイパーサーミア装置市場
    • ドイツのハイパーサーミア装置市場
    • イタリアのハイパーサーミア装置市場
    • スペインのハイパーサーミア装置市場
    • 英国のハイパーサーミア装置市場
    • その他欧州のハイパーサーミア装置市場
  • アジア太平洋
    • 主要な市場動向と機会
    • 中国のハイパーサーミア装置市場
    • 日本のハイパーサーミア装置市場
    • インドのハイパーサーミア装置市場
    • 韓国のハイパーサーミア装置市場
    • オーストラリアのハイパーサーミア装置市場
    • その他アジア太平洋のハイパーサーミア装置市場
  • ラテンアメリカ、中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのハイパーサーミア装置市場
    • 南アフリカのハイパーサーミア装置市場
    • サウジアラビアのハイパーサーミア装置市場
    • その他のラテンアメリカ、中東・アフリカのハイパーサーミア装置市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第9章 企業プロファイル

  • Pyrexar Medical
  • Oncotherm
  • Celsius42
  • Andromedic
  • Pearson
  • Nanjing Greathope
  • Shanghai Huayuan
  • MagForce AG
  • Nanopores
  • Sensius
目次
Product Code: A324444

The hyperthermia devices market was valued at $168.2 million in 2023, and is projected to reach $290.1 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Hyperthermia Devices Market - IMG1

Hyperthermia devices are medical instruments used to raise the temperature of body tissues for therapeutic purposes, often as an adjunct treatment for cancer. By applying controlled heat to specific areas of the body, these devices enhance the efficacy of treatments like chemotherapy and radiation therapy by improving blood flow and increasing the sensitivity of cancer cells to treatment.

The growth of the global hyperthermia devices market is driven by global increase in cancer cases has driven demand for innovative treatment modalities, including hyperthermia devices, which improve the efficacy of traditional cancer therapies like chemotherapy and radiation. According to a 2022 study published by the World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Thus, with patients increasingly seeking less invasive cancer treatments, hyperthermia devices have gained popularity due to their ability to target localized tissues with minimal side effects compared to conventional approaches. In addition, increase in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice. Moreover, rise in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice, thus fostering the market growth. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aging is associated with a decline in immune system efficiency, including reduced surveillance for abnormal or cancerous cells. This has created a significant demand for advanced therapeutic options, including hyperthermia devices. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. The growth of specialized oncology clinics and hospitals worldwide has further facilitated the adoption of advanced cancer treatment modalities, such as hyperthermia therapy, to improve patient outcomes. Despite its benefits, hyperthermia therapy remains underutilized due to limited awareness and training among healthcare providers about its effectiveness and integration into cancer treatment protocols. The cost of hyperthermia treatment, including the devices and associated procedures, can be prohibitive for many patients and healthcare systems, particularly in low- and middle-income regions, further restraining the market growth. On the contrary, Technological innovations, such as improved thermal delivery systems, real-time temperature monitoring, and non-invasive devices, have enhanced the safety, precision, and effectiveness of hyperthermia treatments. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global hyperthermia devices market analysis is segmented into product, application, end user, and region. On the basis of product, the market is categorized into microwave hyperthermia devices and ultrasound hyperthermia devices. Depending on application, it is segregated into breast cancer, prostate cancer, cervical cancer, and others. By end user, it is fragmented into hospitals, cancer treatment centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the ultrasound hyperthermia devices segment is expected to dominate the market from 2024 to 2033.

Depending on application, the prostate cancer segment is anticipated to exhibit the highest growth throughout the forecast period.

By end user, the hospitals segment is projected to grow at a notable pace during the forecast period.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

The major players operating in the global hyperthermia devices Market include Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, and Sensius. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product

  • Microwave Hyperthermia Devices
  • Ultrasound Hyperthermia Devices

By Application

  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Others

By End User

  • Hospitals
  • Cancer treatment centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Pyrexar Medical
    • Oncotherm
    • Celsius42
    • Andromedic
    • Pearson
    • Nanjing Greathope
    • Shanghai Huayuan
    • MagForce AG
    • Nanopores
    • Sensius

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: HYPERTHERMIA DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Microwave Hyperthermia Devices
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Ultrasound Hyperthermia Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: HYPERTHERMIA DEVICES MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Breast Cancer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Prostate Cancer
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cervical Cancer
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: HYPERTHERMIA DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Cancer Treatment Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: HYPERTHERMIA DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Hyperthermia Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Hyperthermia Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Hyperthermia Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Hyperthermia Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Hyperthermia Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Hyperthermia Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Hyperthermia Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Hyperthermia Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Hyperthermia Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Hyperthermia Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Hyperthermia Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Hyperthermia Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Hyperthermia Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Hyperthermia Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Hyperthermia Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Hyperthermia Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Hyperthermia Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Hyperthermia Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Hyperthermia Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Pyrexar Medical
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Oncotherm
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Celsius42
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Andromedic
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Pearson
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Nanjing Greathope
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Shanghai Huayuan
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MagForce AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Nanopores
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Sensius
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments